CHOLECYSTOKININ-INDUCED RELEASE OF DOPAMINE IN THE NUCLEUS-ACCUMBENS OF THE SPONTANEOUSLY HYPERTENSIVE RAT

被引：9

作者：

KIROUAC, GJ

GANGULY, PK

机构：

[1] UNIV MANITOBA,FAC MED,DEPT ANAT,WINNIPEG,MB R3E 0W3,CANADA

[2] ST BONIFACE GEN HOSP,RES CTR,DIV CARDIOVASC SCI,WINNIPEG,MB R3E 0W3,CANADA

来源：

BRAIN RESEARCH | 1995年 / 689卷 / 02期

关键词：

MICRODIALYSIS; DOPAMINE; NUCLEUS ACCUMBENS; CHOLECYSTOKININ; SPONTANEOUSLY HYPERTENSIVE RAT;

D O I：

10.1016/0006-8993(95)00584-D

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Changes in dopamine neurotransmission in the nucleus accumbens of the spontaneously hypertensive rat (SHR) may be involved in the pathogenesis of hypertension. This investigation tested the hypothesis that the sulfated octapeptide cholecystokinin (CCK8S) induced release of dopamine is greater in the SHR than in its normotensive control, the Wistar-Kyoto rat (WKY). Dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were sampled using microdialysis in the caudal half of the nucleus accumbens of 10-week-old anesthetized SHRs and WKYs. Samples were collected in the following order: 3 baseline, 3 CCK8S (10 mu mol/l), and 3 postdrug samples. The samples were then analyzed using high pressure liquid chromatography with electrochemical detection. CCK8S increased dopamine and DOPAC levels in both the SHR and WKY with a larger increase in basal dopamine in the SHR (greater than 200%). Perfusion of the nucleus accumbens with 1 mu mol/l of CCK8S or the nonsulfated form of CCK8 (CCK8US, 10 mu mol/l) produced no significant increase in the release of dopamine in the SHR. These results indicate that CCK8S-induced release of dopamine in the nucleus accumbens is greater in the SHR. Changes in CCK8S neurotransmission/receptor function may be responsible for the alterations in dopaminergic function of the SHR and the pathogenesis of hypertension.

引用

页码：245 / 253

页数：9

共 42 条

[21]

Meyer, Protopapas, Studies on cholecystokinin-containing neuronal pathways in rat cerebral cortex and striatum, Ann. NY Acad. Sci., 448, pp. 133-143, (1985)

[22]

Mok, Sim, The actions of dopamine on the blood pressure and heart rate of conscious hypertensive rats: evidence for reduced dopaminergic activity in rats of the Japanese strains, Clin. Exp. Hypertens., 9 A, pp. 1615-1635, (1987)

[23]

Nagahama, Chen, Oparil, Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat, J. Pharmacol. Exp. Ther., 228, pp. 370-375, (1984)

[24]

Paxinos, Watson, The Rat Brain in Stereotaxic Coordinates, (1982)

[25]

Rehfeld, Neuronal cholecystokinin: one or multiple transmitters?, J. Neurochem., 44, pp. 1-10, (1985)

[26]

Ruggeri, Ungerstedt, Agnati, Mutt, Harfstrand, Fuxe, Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat, Neurochem. Int., 10, pp. 509-520, (1987)

[27]

Seroogy, Dangaran, Lim, Haycock, Fallon, Ventral mesencephalic neurons containing both cholecystokinin-and tyrosine-like immunoreactivities project to forebrain regions, J. Comp. Neurol., 279, pp. 397-410, (1989)

[28]

Seroogy, Fallon, Forebrain projections from cholecystokinin like -immunoreactive neurons in the rat midbrain, J. Comp. Neurol., 279, pp. 414-435, (1989)

[29]

Seroogy, Schalling, Brene, Dagerlind, Chai, Hokfelt, Persson, Brownstein, Dixon, Filer, Schlessinger, Goldstein, Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rats mesencephalon: peptide/monoamines coexistence studies using in situ hybridization combined with immunocytochemistry, Exp. Brain Res., 176, pp. 1-14, (1988)

[30]

Shulkes, Lewis, Jarrott, Strain differences in central nervous system concentrations of cholecystokinin between normotensive Wistar Kyoto (WKY) and spontaneously hypertensive (SH) rats, Neuropeptides, 14, pp. 59-64, (1989)

← 1 2 3 4 5 →